GlassScriptPhysician profile
Milam C Raemsch
NPI 1649652256
$5,104.06
in general payments reported to CMS, 2019-2025
28 companies · $623 in 2025
The $623 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,623 · 2020: $163 · 2021: $297 · 2022: $612 · 2023: $601 · 2024: $1,185 · 2025: $623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,398 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,397.54 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,368.25 | 2019-2025 | Citrefix, Flexband, Augment Injectable |
| Wright Medical Technology, INC. | $1,268.80 | 2019-2020 | |
| Treace Medical Concepts, INC. | $878.56 | 2022-2025 | |
| Organogenesis INC. | $483.90 | 2022-2025 | Puraply, Puraply Antimicrobial, Via Matrix |
| Smith+Nephew, INC. | $188.49 | 2023-2024 | Grafix Pl, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Bioventus LLC | $186.88 | 2020-2025 | Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $156.76 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Mimedx Group, INC. | $70.03 | 2024-2025 | |
| Medtronic, INC. | $47.06 | 2024-2025 | Intellis Adaptivestim |
| Orthofix Medical, INC. | $38.93 | 2019-2020 | |
| Biotissue Holdings INC. | $37.49 | 2022 | |
| Horizon Therapeutics Plc | $36.54 | 2022 | |
| Abbott Laboratories | $32.64 | 2019-2025 | Proclaim |
| Nevro Corp. | $32.48 | 2022 | |
| Melinta Therapeutics, LLC | $32.16 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $31.62 | 2019 | |
| Zyla Life Sciences, INC. | $29.31 | 2020 | |
| Hartmann USA, INC. | $22.02 | 2024 | Zetuvit Plus 10x10 P10 |
| Kci USA, INC. | $21.38 | 2020 | |
| Averitas Pharma INC. | $19.75 | 2024 | Qutenza |
| Abbvie INC. | $17.96 | 2024 | |
| Depuy Synthes Sales INC. | $16.49 | 2024 | |
| Anika Therapeutics, INC. | $15.78 | 2021 | |
| Reprise Biomedical, INC. | $15.32 | 2025 | Miro3d |
| Davol INC. | $14.70 | 2023 | Arista Ah Flexitip |
| Integra Lifesciences Corporation | $14.43 | 2022 | |
| Convatec INC. | $13.48 | 2023 | |
| Allergan, INC. | $12.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milam Raemsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.